A R T I C L E S
Dai and Etzkorn
1257.9, found 1257.8; [M + 3H]3+/3 calcd for C121H176N29O30/3
838.9, found 838.8. Control peptide 3: retention time 7.9 min; MS
m/z [M + 2H]2+/2 calcd for C120H174N30O31/2 1266.4, found 1266.3;
[M + 3H]3+/3 calcd for C120H175N30O31/3 844.6, found 844.6.
CD Analysis. The concentrations of peptides in PBS (0.27 mM
KCl, 13.7 mM NaCl, 0.15 mM KH2PO4, 0.81 mM Na2HPO4 in
H2O, pH 7.4) were determined by weight; peptide 2 was 1.32 mg/
mL, and control peptide 3 was 1.26 mg/mL. The peptide solutions
were incubated at 5 °C for more than 48 h. The CD spectra were
obtained with a spectropolarimeter in 0.5 nm increments, 1 nm
bandwidth, and 0.2 cm path length at a scan speed of 100 nm/min.
The spectra were averaged over four consecutive scans. The
solutions were heated from 2 to 70 °C in 3 °C increments with a
10 min equilibration time at each temperature before measurement.
The temperature was measured in the cell. The ellipticity at 227
nm was monitored at each temperature and averaged over four
consecutive measurements. The unfolding process of each peptide
was measured twice, and the data obtained were processed
separately and averaged to obtain the Tm value (Supporting
Information, Figures S1 and S2). The data were fit to the following
equations using SigmaPlot v.10.0:24,25
phase synthesis to reduce the number of steps in the solution-
phase organic synthesis of the isostere. The dipeptide alkene
isostere 1 was coupled with HATU-HOAt, with no external
base added, to prevent isomerization to the R,ꢀ-unsaturated
activated ester,23 and the coupling was monitored by reverse-
phase HPLC. No double bond migration was observed. There
was only one peak with the desired mass in the LC-MS
chromatogram, and the presence of the alkene proton was
confirmed by NMR (Supporting Information). Peptides 2 and
3 were obtained as white solids after purification by RP HPLC
on a protein C4 column.
CD Analysis. The isostere peptide 2 lacked an interchain
backbone hydrogen bond that was present in the Pro-Pro-Gly
host system, so we expected that peptide 2 would have a lower
Tm value than 3. The melting point would not be measurable in
ordinary phosphate-buffered saline (PBS) if Tm was too low.
Trimethylamino N-oxide (TMAO) has been used to study the
unfolding stability of peptides and proteins.22,28,29 TMAO is a
natural osmolyte, which can thermodynamically stabilize folded
proteins against the denaturation process by reducing the degree
of backbone solvation.29-32 Beck et al. found that the Tm value
of unstable collagen peptides was linearly dependent on the
concentration of TMAO.28 Jenkins et al. used the same method
to measure the melting temperatures of an ester isostere and
Pro-trans-Gly isostere 4 collagen peptides by extrapolating the
data to 0 M TMAO.22
For optimal comparison, we measured Tm under exactly the
same conditions that were reported for the Pro-trans-Gly isostere
peptide 4.22 Both the Pro-trans-Pro isostere peptide 2 and control
peptide 3 were dissolved in 9.6 mM PBS buffer pH 7.4 with
different concentrations of TMAO. For the Pro-trans-Pro
isostere peptide 2, the full-range CD spectrum showed a
maximum near 225 nm when the TMAO concentration was
higher than 2.5 M, which indicated the presence of the PPII
helix, and the ellipticity of the peptide increased with increasing
TMAO concentration (Figure 2). When the TMAO concentra-
tion was greater than 2.5 M, peptide 2 showed cooperative
denaturation with increasing temperature, indicating the presence
of a collagen triple helix (Figure 3). Peptide 3 showed
cooperative denaturation with increasing temperature at all
TMAO concentrations (Figure 3).
The Tm values at each TMAO concentration were determined
by fitting the data to a two-state model. Extrapolating the data
to 0 M TMAO gave a melting point of -22.0 ( 1.9 °C for
isostere peptide 2 (Figure 4 and Table 1). The melting point of
control peptide 3, obtained by extrapolating the Tm value to 0 M
TMAO, was determined to be 31.6 °C (Figure 4 and Table 1).
This Tm value was very close to the measured Tm value of
31.5 °C in 9.6 mM PBS buffer with no TMAO present. It was
also close to the literature Tm value of 32.8 °C determined in
the same PBS buffer.33
-∆G0U(T)
(a + b T) + (a + b T) exp
(
)
n
n
d
1 + exp
T
d
RT
Θ )
-∆G0U(T)
(
)
RT
T
∆G0U(T) ) ∆H0(Tm) 1 -
- ∆C0p (Tm - T) + T ln
(
)
( )
[
]
Tm
Tm
∆C0p ) 0
Results
Synthesis. The Pro-trans-Pro isostere 1 was designed with
the (S,R)-stereochemistry to mimic the all-L natural amino acids
found in collagen. Due to the challenges of the synthetic
chemistry, and in order to compare peptide 2 directly with Pro-
trans-Gly isostere peptide 4, we chose the same host peptide,
H-(Pro-Pro-Gly)10-OH (3) (Figure 1).22 The Pro-trans-Pro alkene
isostere 2 eliminated cis-trans isomerization by locking one
Pro amide bond in the trans conformation, and it also lacked
an essential Gly NsH to Xaa Pro CdO hydrogen bond.
Our method for the stereoselective synthesis of the Ser-Ψ[(E)-
CHdC]-Pro and Gly-Ψ[(E)CHdC]-Pro isosteres has been
reported.23,26 Dipeptide isostere 1 has a structure similar to that
of these compounds, so we used our well-developed method
for the synthesis. The synthesis of a Pro-trans-Pro (E)-alkene
isostere with slight variations from our method has been
reported, but the key Ireland-Claisen rearrangement was the
same.27 The R-hydroxycarboxylic acid intermediate was reduced
to the alcohol and crystallized to prove the stereochemistry,27
while we used NMR to establish the stereochemistry. The details
of the synthesis and characterization of 1 are included in the
Supporting Information.
Discussion
Peptide 2, which contains the Pro-trans-Pro alkene isostere,
and control peptide 3 were synthesized by coupling Fmoc-Pro-
Pro-Gly-OH tripeptide units in solid-phase peptide synthesis.23
The Gly residue of the isostere triplet was coupled during solid-
The Gly-Pro isostere peptide 5 showed a ∆Tm of -21.2 °C,
the Pro-Pro isostere peptide 2 showed a ∆Tm of -53.6 °C,
and the Pro-Gly isostere peptide 4 showed a ∆Tm of -57.5 °C
compared to each of their control peptides, respectively (Table
(24) Becktel, W. J.; Schellman, J. A. Biopolymers 1987, 26, 1859–1877.
(25) Horng, J. C.; Hawk, A. J.; Zhao, Q.; Benedict, E. S.; Burke, S. D.;
Raines, R. T. Org. Lett. 2006, 8, 4735–4738.
(28) Beck, K.; Chan, V. C.; Shenoy, N.; Kirkpatrick, A.; Ramshaw, J. A.;
Brodsky, B. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 4273–4278.
(29) Baskakov, I.; Bolen, D. W. J. Biol. Chem. 1998, 273, 4831–4834.
(30) Liu, Y.; Bolen, D. W. Biochemistry 1995, 34, 12884–12891.
(31) Wang, A.; Bolen, D. W. Biochemistry 1997, 36, 9101–9108.
(32) Bolen, D. W.; Baskakov, I. V. J. Mol. Biol. 2001, 310, 955–963.
(26) Wang, X. J.; Xu, B.; Mullins, A. B.; Neiler, F. K.; Etzkorn, F. A.
J. Am. Chem. Soc. 2004, 126, 15533–15542.
(27) Bandur, N. G.; Harms, K.; Koert, U. Synlett 2005, 2005, 773–776.
9
13730 J. AM. CHEM. SOC. VOL. 131, NO. 38, 2009